Cliff Asness’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-39,583
| Closed | -$166K | – | 2332 |
|
|
2023
Q1 | $166K | Buy |
39,583
+3,430
| +9% | +$17.8K | ﹤0.01% | 2077 |
|
|
2022
Q4 | $217K | Buy |
36,153
+13,154
| +57% | +$71.8K | ﹤0.01% | 2061 |
|
|
2022
Q3 | $134K | Buy |
22,999
+7,634
| +50% | +$47.6K | ﹤0.01% | 2091 |
|
|
2022
Q2 | $92K | Hold |
15,365
| – | – | ﹤0.01% | 2101 |
|
|
2022
Q1 | $72K | Hold |
15,365
| – | – | ﹤0.01% | 2164 |
|
|
2021
Q4 | $38K | Hold |
15,365
| – | – | ﹤0.01% | 2183 |
|
|
2021
Q3 | $45K | Hold |
15,365
| – | – | ﹤0.01% | 2227 |
|
|
2021
Q2 | $38K | Hold |
15,365
| – | – | ﹤0.01% | 2212 |
|
|
2021
Q1 | $45K | Hold |
15,365
| – | – | ﹤0.01% | 2174 |
|
|
2020
Q4 | $49K | Hold |
15,365
| – | – | ﹤0.01% | 2176 |
|
|
2020
Q3 | $33K | Hold |
15,365
| – | – | ﹤0.01% | 2170 |
|
|
2020
Q2 | $18K | Hold |
15,365
| – | – | ﹤0.01% | 2097 |
|
|
2020
Q1 | $14K | Buy |
+15,365
| New | +$17.6K | ﹤0.01% | 2030 |
|
|
2017
Q1 | – | Sell |
-8,070
| Closed | -$33K | – | 2333 |
|
|
2016
Q4 | $33K | Hold |
8,070
| – | – | ﹤0.01% | 2220 |
|
|
2016
Q3 | $30K | Hold |
8,070
| – | – | ﹤0.01% | 2240 |
|
|
2016
Q2 | $27K | Hold |
8,070
| – | – | ﹤0.01% | 2185 |
|
|
2016
Q1 | $43K | Hold |
8,070
| – | – | ﹤0.01% | 2199 |
|
|
2015
Q4 | $99K | Hold |
8,070
| – | – | ﹤0.01% | 2213 |
|
|
2015
Q3 | $118K | Sell |
8,070
-3,890
| -33% | -$67.2K | ﹤0.01% | 2116 |
|
|
2015
Q2 | $233K | Hold |
11,960
| – | – | ﹤0.01% | 2064 |
|
|
2015
Q1 | $216K | Hold |
11,960
| – | – | ﹤0.01% | 1996 |
|
|
2014
Q4 | $282K | Hold |
11,960
| – | – | ﹤0.01% | 2229 |
|
|
2014
Q3 | $289K | Hold |
11,960
| – | – | ﹤0.01% | 2204 |
|
|
2014
Q2 | $336K | Hold |
11,960
| – | – | ﹤0.01% | 2158 |
|
|
2014
Q1 | $407K | Buy |
+11,960
| New | +$409K | ﹤0.01% | 2145 |
|
Other funds holding CTIC
Cliff Asness's CTIC Position: Q2 2023 in Review
Cliff Asness sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 39,583 shares — an estimated $166K sold.
Cliff Asness first reported a position in CTIC in Q1 2014 and held it in 25 quarters. The position peaked at $407K in Q1 2014. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Cliff Asness reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Cliff Asness sold 39,583 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $166K.
- Cliff Asness first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2014 and held it in 25 quarters.
- Cliff Asness's CTI BioPharma Corp. (DE) Common Stock position peaked at $407K in Q1 2014.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on AQR Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.